Table 3 Correlation between SCD risk score, PET/CT data 2-[18F]FDG uptake (TBR and hypermetabolism extension); myocardial scar/fibrosis (global and segmental) and CMR data (LGE).

From: 2-[18F]FDG PET identifies metabolic substrates of sudden cardiac death in hypertrophic cardiomyopathy

 

PET/CT—TBR

Global

Anterior

Septal

Inferior

Lateral

Apical

SCD score

 Rho

0.38

0.44

0.32

0.44

0.28

0.46

 P value

0.036*

0.016*

0.087

0.016*

0.131

0.011*

 

PET/CT—hypermetabolism extension

Global

Anterior

Septal

Inferior

Lateral

Apical

SCD score

 Rho

0.26

0.22

0.28

0.47

0.33

0.24

 P value

0.167

0.247

0.136

0.008*

0.073

0.199

 

PET/CT—Fibrosis/Scar extension

Global

Anterior

Septal

Inferior

Lateral

Apical

SCD score

 Rho

0.38

0.40

0.51

0.08

0.282

0.157

 P value

0.039*

0.030*

0.004*

0.657

0.131

0.409

 

CMR—LGE extension

Global

Anterior

Septal

Inferior

Lateral

Apical

SCD score

 Rho

0.45

0.33

0.48

0.08

0.35

0.01

 P value

0.035*

0.13

0.023*

0.738

0.098

0.941

  1. CMR, cardiac magnetic resonance; SCD, sudden cardiac death; TBR, tissue to background ratio.
Back to article page